Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.


In the US, Sincalide (sincalide systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Barium Meal Transit, Gallbladder Contraction and Pancreatic Secretion.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Diagnostic agent: Gall-bladder function

Chemical Name

Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-

Foreign Names

  • Sincalidum (Latin)
  • Sincalid (German)
  • Sincalide (French)
  • Sincalida (Spanish)

Generic Names

  • Sincalide (OS: BAN, USAN)
  • CCK 8 (IS)
  • SQ 19844 (IS: Squibb)
  • Sincalide for Injection (PH: USP 34)

Brand Name


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.